Victoria Costa Paz
Victoria Costa Paz is the co-founder and CEO of Eywa Biotech, a pioneering biotech company dedicated to revolutionizing the production of psychedelic compounds through synthetic biology. Eywa's mission is to make these APIs pharmaceutical-grade, scalable, sustainable, and accessible, redefining mental health treatment and innovation. Born in Buenos Aires, Argentina, Victoria earned a Bachelor’s degree in Communications and a Master’s in Business and Technology. Before venturing into entrepreneurship, she gained extensive experience working for global corporations such as The Coca-Cola Company and Santander Bank. Victoria began her entrepreneurial journey six years ago and now she's focused on creating impactful solutions at the intersection of biotechnology, business and mental health, positioning Eywa Biotech as a leader in sustainable and scalable psychedelic compound production in Latin America.
Eywa Biotech
Synthesizing Psychedelics: Unpacking the Options for Psychedelics Production
-
In this session we will explore the many methods of producing psychedelic and psychedelic-inspired compounds for clinical applications. The discussion will center around the pros and cons of a synthetic biology-based approach as compared with chemical synthetic and natural product extraction-based approaches. We will discuss topics such as environmental sustainability, scalability, technology transfer, and cost, as well as how future disrupting technologies could impact this emerging field.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
